Source link : https://www.newshealth.biz/health-news/pfizers-withdrawal-of-scd-drug-raises-questions/
The global withdrawal of voxelotor (Oxbryta, Pfizer) has left clinicians who treat sickle cell disease (SCD) with the urgent task of reaching patients taking the medicine, while trying to understand why it was taken off the market. The National Alliance of Sickle Cell Centers issued a statement urging patients not to stop voxelotor abruptly. Instead, […]
Author : News Health
Publish date : 2024-09-30 06:51:45
Copyright for syndicated content belongs to the linked Source.
inHealth